Part 3: Evaluating Study Status and Leveraging Data Monitoring Committees to Make Study Decisions

Our panelists discuss best practices for:

• Evaluating whether there is enough reliable data to draw meaningful clinical study conclusions
• Assessing the status of each clinical study – what challenges and opportunities are presented based on study characteristics and timeline?
• Determining how studies can be designed now to build in future flexibility in schedules, procedures and analysis plans
• Leveraging DMCs/DSMBs to play a role in the assessment and modification of studies
• Revisiting safety data collection and reporting during the COVID-19 crisis